Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?
Ocular Therapeutix Ownership Summary
Ocular Therapeutix is owned by 109.93% institutional investors, 0.87% insiders. Fmr is the largest institutional shareholder, holding 14.66% of OCUL shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.98% of its assets in Ocular Therapeutix shares.
OCUL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ocular Therapeutix | 109.93% | 0.87% | -10.80% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 32.84M | 14.66% | $322.53M |
| Deep track capital, lp | 19.69M | 8.78% | $193.32M |
| Blackrock | 11.52M | 8.73% | $78.80M |
| Blackrock funding, inc. /de | 19.38M | 8.65% | $190.28M |
| Vanguard group | 11.58M | 6.29% | $140.52M |
| Avoro capital advisors | 12.54M | 5.60% | $123.14M |
| Summer road | 12.21M | 5.45% | $119.89M |
| Vr adviser | 10.35M | 4.62% | $101.61M |
| Vanguard capital management | 8.83M | 3.94% | $86.74M |
| Price t rowe associates inc /md/ | 7.62M | 3.40% | $74.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Summer road | 12.21M | 74.46% | $119.89M |
| Knoll capital management | 1.15M | 6.30% | $11.30M |
| Acuta capital partners | 532.48K | 3.64% | $5.23M |
| Deltec asset management | 2.48M | 3.59% | $24.32M |
| Vr adviser | 10.35M | 3.08% | $101.61M |
| Deep track capital, lp | 19.69M | 2.81% | $193.32M |
| Logos global management lp | 5.30M | 2.24% | $52.05M |
| Propel bio management | 357.97K | 1.84% | $3.52M |
| Octagon capital advisors lp | 2.08M | 1.83% | $20.38M |
| Beacon investment advisors | 435.13K | 1.34% | $4.27M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 11.52M | 0.00% | 3.46M |
| Blackrock funding, inc. /de | 19.38M | 0.00% | 3.24M |
| Vanguard group | 11.58M | 0.00% | 2.41M |
| Dimensional fund advisors lp | 2.78M | 0.01% | 2.13M |
| Price t rowe associates inc /md/ | 7.62M | 0.01% | 1.73M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 68.50K | 0.00% | -4.16M |
| Alliancebernstein | 227.02K | 0.00% | -3.90M |
| Paradigm biocapital advisors lp | - | - | -2.94M |
| Commodore capital lp | - | - | -2.58M |
| Point72 asset management | 3.29M | 0.04% | -2.24M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 1.53M | 0.00% | 1.53M | $15.06M |
| Driehaus capital management | 518.75K | 0.04% | 518.75K | $6.06M |
| Axa investment managers | 439.88K | 0.01% | 439.88K | $5.14M |
| Cantor fitzgerald, l. p. | 201.87K | 0.02% | 201.87K | $2.36M |
| Csm advisors | 190.19K | 0.04% | 190.19K | $1.87M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Federated hermes | -2.00 |
| Optiver b.v. | -10.00 |
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Twin peaks wealth advisors | -19.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 275 | 4.17% | 205,831,607 | 7.46% | 109 | 1.05% | 174 | 4.82% | 60 | 1.69% |
| Dec 31, 2025 | 60 | -73.68% | 18,632,527 | -90.10% | 10 | 0.09% | 31 | -74.59% | 17 | -71.67% |
| Sep 30, 2025 | 70 | -63.92% | 30,539,013 | -80.55% | 17 | 0.21% | 28 | -71.43% | 23 | -51.06% |
| Jun 30, 2025 | 192 | -4.48% | 156,898,610 | 16.16% | 90 | 1.43% | 96 | 3.23% | 47 | -20.34% |
| Mar 31, 2025 | 202 | 8.60% | 137,366,906 | 2.63% | 81 | 1.26% | 93 | -1.06% | 60 | 57.89% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 13.13M | 5.98% | - |
| Fidelity Growth Company Fund | 9.70M | 4.42% | -11.99K |
| Vanguard Total Stock Mkt Idx Inv | 6.62M | 3.02% | 31.18K |
| Vanguard Morn Total Stk Mkt Idx Investor | 6.62M | 3.02% | 31.18K |
| Vanguard US Total Market Shares ETF | 4.64M | 2.92% | - |
| iShares Russell 2000 ETF | 5.17M | 2.35% | -91.87K |
| Fidelity Growth Company K6 | 2.70M | 1.23% | 11.99K |
| Fidelity Series Growth Company | 2.61M | 1.19% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.00M | 0.91% | 31.05K |
| Fidelity Small Cap Index | 1.88M | 0.86% | 18.32K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 03, 2026 | Waheed Nadia | Chief Medical Officer | Sell | $122.63K |
| May 26, 2026 | Dugel Pravin | See Remarks | Sell | $173.48K |
| May 26, 2026 | Kaiser Peter | Chief Development Officer | Sell | $24.33K |
| May 26, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | $24.75K |
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | $15.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 5 |
| 2026 Q1 | 1 | 11 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | 1 | 5 |
OCUL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools